Trial intelligence / Profile preview

Edoxaban for portal vein thrombosis in chronic liver disease (PVTED study)

jRCTs041190015Completed

Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of edoxaban in portal vein thrombosis (PVT). Primary endpoint: Portal vein thrombus reduction rate. Started Jan 2018; status: completed.

02

Drugs

edoxaban
03

Conditions

portal vein thrombosis (PVT)

Beyond the preview

Go deeper on jRCTs041190015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041190015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call